Duality Biotherapeutics Inc (9606)

Hong Kong
Currency in HKD
283.00
+8.00(+2.91%)
Closed·
9606 Scorecard
Full Analysis
Net income is expected to grow this year
9606 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
270.20285.00
52 wk Range
165.50289.80
Key Statistics
Edit
Bid/Ask
281.60 / 283.00
Prev. Close
275
Open
270.2
Day's Range
270.2-285
52 wk Range
165.5-289.8
Volume
155.85K
Average Volume (3m)
625.78K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
9606 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
313.49
Upside
+10.77%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Duality Biotherapeutics Inc News & Analysis

Show more

Duality Biotherapeutics Inc Company Profile

Duality Biotherapeutics, Inc., a clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others. The company provides DB-1303/BNT323, a HER2 ADC candidate targeting cancers, including endometrial cancer1 and breast cancer2; DB-1311/BNT324, a B7-H3 ADC candidate targeting cancers, such as small-cell lung cancer3, castration-resistant prostate cancer4, esophageal squamous cell carcinoma5, and head and neck squamous cell carcinoma; and other clinical-stage ADCs. It has strategic partnerships with BioNTech SE to develop therapies to complement or replace chemotherapy; and BeiGene, Ltd. to develop and commercialize DB-1312, an in-house discovered B7-H4- targeted ADC. The company was incorporated in 2019 and is headquartered in Shanghai, China.

Employees
170
Market
Hong Kong

Compare 9606 to Peers and Sector

Metrics to compare
9606
Peers
Sector
Relationship
P/E Ratio
−21.1x−15.5x−0.5x
PEG Ratio
0.110.400.00
Price/Book
-5.5x2.6x
Price / LTM Sales
11.4x18.2x3.0x
Upside (Analyst Target)
−1.5%9.6%49.2%
Fair Value Upside
Unlock−16.1%7.4%Unlock

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 313.49
(+10.77% Upside)

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

9606 Income Statement

People Also Watch

68.00
9995
+5.43%
24.55
1530
0.00%
82.35
1801
-0.24%
109.80
9926
-2.83%

FAQ

What Is the Duality Biotherapeutics (9606) Stock Price Today?

The Duality Biotherapeutics stock price today is 283.00

What Stock Exchange Does Duality Biotherapeutics Trade On?

Duality Biotherapeutics is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Duality Biotherapeutics?

The stock symbol for Duality Biotherapeutics is "9606."

What Is the Duality Biotherapeutics Market Cap?

As of today, Duality Biotherapeutics market cap is 24.21B.

What Is Duality Biotherapeutics's Earnings Per Share (TTM)?

The Duality Biotherapeutics EPS (TTM) is -131.30.

From a Technical Analysis Perspective, Is 9606 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Duality Biotherapeutics Stock Split?

Duality Biotherapeutics has split 0 times.

How Many Employees Does Duality Biotherapeutics Have?

Duality Biotherapeutics has 170 employees.

What is the current trading status of Duality Biotherapeutics (9606)?

As of 08 July 2025, Duality Biotherapeutics (9606) is trading at a price of 283.00, with a previous close of 275.00. The stock has fluctuated within a day range of 270.20 to 285.00, while its 52-week range spans from 165.50 to 289.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.